Exit

EXIT-CVD research consortium launches clinical studies 

HTP Desk - 0
Asian

Asian Labs and AmeriHealth Home Healthcare inaugurate Gurugram Facility

HTP Desk - 0
USP

Regulatory spotlight: USP

HTP Desk - 0
plasma

Plasma solutions for reliable surface treatment processes in medical technology

HTP Desk - 1
Prostate

New ultrasound technology for the prostate

HTP Desk - 0
Syntegon

Syntegon launches Annex 1 roadshow to bring solutions To pharma customers

HTP Desk - 0
BioDuro

BioDuro appoints Greg Makara as senior VP

HTP Desk - 0
drug

Experts flag rising threat of drug-resistant superbugs 

HTP Desk - 0
health

Second World Summit on Sustainable Health and Well-Being 2026

HTP Desk - 0
CEVIRA (APL-1702) is a photodynamic drug-device combination product being developed for the non-surgical treatment of cervical precancerous lesions associated with HPV.

Asieris Pharmaceuticals’ licensing agreement with Theramex for Cevira

HTP Desk - 1
123...225Page 1 of 225